Comprehensive proteomic analysis of host cell lipid rafts modified by HBV infection

Journal of Proteomics

Volumn 75, Issue 3, 2012, Pages 725-739

  Xie, Na ^a   Huang, Kai ^a   Zhang, Tao ^a,b   Lei, Yunlong ^a   Liu, Rui ^a   Wang, Kui ^a   Zhou, Shengtao ^a   Li, Jingyi ^a   Wu, Jinhua ^a   Wu, Hong ^a   Deng, Cao ^a   Zhao, Xia ^a   Nice, Edouard Collins ^c   Huang, Canhua ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU MEDICAL COLLEGE   (China)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Bioinformatics; Hepatitis B virus; HepG2.2.15; Lipid rafts; Proteomics

Indexed keywords

40S RIBOSOMAL PROTEIN SA; ADENYLATE CYCLASE TYPE 7; ALPHA ENOLASE; ARMADILLO DOMAIN PROTEIN; ARMADILLO REPEAT CONTAINING X LINKED PROTEIN 1; BETA ACTIN; CADMIUM 109; CALPAIN 1; CALRETICULIN; CAVEOLIN 1; CD147 ANTIGEN; CD71 ANTIGEN; CN37 PROTEIN; COATOMER PROTEIN; CYTOCHROME B; DIPEPTIDYL PEPTIDASE IV; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL 17BETA DEHYDROGENASE; FIBROCYSTIN; FLOTILLIN 1; GALECTIN 1; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; HERMES ANTIGEN; LIPOCORTIN 1; LIPOCORTIN 4; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RIBOSOME PROTEIN; STOMATIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS PROTEIN;

ARTICLE; BIOINFORMATICS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL MEDIATED CYTOTOXICITY; CELL VIABILITY; CONTROLLED STUDY; HEPATITIS B; HOST CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIPID RAFT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN TRANSPORT; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY; UNINDEXED SEQUENCE;

BETA-CYCLODEXTRINS; BIOLOGICAL TRANSPORT, ACTIVE; CELL ADHESION; CHOLESTEROL; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MEMBRANE MICRODOMAINS; PROTEOMICS; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 84355162943     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.09.011     Document Type: Article

References (65)

1. Pairan A., Bruss V. Functional surfaces of the hepatitis B virus capsid. J Virol 2009, 83:11616-11623.
2. Patient R., Hourioux C., Roingeard P. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell Microbiol 2009, 11:1561-1570.
3. WHO Fact sheet no. 204.
4. Patient R., Hourioux C., Sizaret P.Y., Trassard S., Sureau C., Roingeard P. Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking. J Virol 2007, 81:3842-3851.
5. Metzner C., Salmons B., Gunzburg W.H., Dangerfield J.A. Rafts, anchors and viruses-a role for glycosylphosphatidylinositol anchored proteins in the modification of enveloped viruses and viral vectors. Virology 2008, 382:125-131.
6. Ono A., Freed E.O. Role of lipid rafts in virus replication. Adv Virus Res 2005, 64:311-358.
7. Chazal N., Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev 2003, 67:226-237. [table of contents].
8. Marsh M., Helenius A. Virus entry: open sesame. Cell 2006, 124:729-740.
9. Pierce S.K. Lipid rafts and B-cell activation. Nat Rev Immunol 2002, 2:96-105.
10. Pike L.J. Lipid rafts: heterogeneity on the high seas. Biochem J 2004, 378:281-292.
11. Allen J.A., Halverson-Tamboli R.A., Rasenick M.M. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 2007, 8:128-140.
12. Gajate C., Del Canto-Janez E., Acuna A.U., Amat-Guerri F., Geijo E., Santos-Beneit A.M., et al. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis. J Exp Med 2004, 200:353-365.
13. Balasubramanian N., Scott D.W., Castle J.D., Casanova J.E., Schwartz M.A. Arf6 and microtubules in adhesion-dependent trafficking of lipid rafts. Nat Cell Biol 2007, 9:1381-1391.
14. Helms J.B., Zurzolo C. Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic 2004, 5:247-254.
15. Manes S., del Real G., Martinez A.C. Pathogens: raft hijackers. Nat Rev Immunol 2003, 3:557-568.
16. Bender F.C., Whitbeck J.C., Ponce de Leon M., Lou H., Eisenberg R.J., Cohen G.H. Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J Virol 2003, 77:9542-9552.
17. Mannová P., Fang R., Wang H., Deng B., McIntosh M.W., Hanash S.M., et al. Modification of host lipid raft proteome upon hepatitis C virus replication. Mol Cell Proteomics 2006, 5:2319-2325.
18. Macovei A., Radulescu C., Lazar C., Petrescu S., Durantel D., Dwek R.A., et al. Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells. J Virol 2010, 84:243-253.
19. Bremer C.M., Bung C., Kott N., Hardt M., Glebe D. Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cell Microbiol 2009, 11:249-260.
20. Kim K.B., Lee J.S., Ko Y.G. The isolation of detergent-resistant lipid rafts for two-dimensional electrophoresis. Methods Mol Biol 2008, 424:413-422.
21. Wang K., Liu R., Li J., Mao J., Lei Y., Wu J., et al. Quercetin induces protective autophagy in gastric cancer cells: Involvement of Akt-mTOR- and hypoxia-induced factor 1alpha-mediated signaling. Autophagy 2011, 7(9):966-978.
22. Li L., Sevinsky J.R., Rowland M.D., Bundy J.L., Stephenson J.L., Sherry B. Proteomic analysis reveals virus-specific Hsp25 modulation in cardiac myocytes. J Proteome Res 2010, 9:2460-2471.
23. Ren F., Wu H., Lei Y., Zhang H., Liu R., Zhao Y., et al. Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma. Mol Cancer 2010, 9:81.
24. Lei Y., Huang K., Gao C., Lau Q.C., Pan H., Xie K., et al. Proteomics identification of ITGB3 as a key regulator in ROS-induced migration and invasion of colorectal cancer cells. Mol Cell Proteomics 2011, 10.1074/mcp.M110.005397.
25. Brass A.L., Huang I.C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139:1243-1254.
26. UniProt C. The universal protein resource (UniProt). Nucleic Acids Res 2007, 35:D193-D197.
27. Zheng Q., Wang X.J. GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res 2008, 36:W358-W363.
28. Kanehisa M., Goto S., Kawashima S., Okuno Y., Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004, 32:D277-D280.
29. Vastrik I., D'Eustachio P., Schmidt E., Gopinath G., Croft D., de Bono B., et al. Reactome: a knowledge base of biologic pathways and processes. Genome Biol 2007, 8:R39.
30. Skopeliti M., Kratzer U., Altenberend F., Panayotou G., Kalbacher H., Stevanovic S., et al. Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation. Proteomics 2007, 7:1814-1824.
31. Schaefer C.F., Anthony K., Krupa S., Buchoff J., Day M., Hannay T., et al. PID: the Pathway Interaction Database. Nucleic Acids Res 2009, 37:D674-D679.
32. Zanzoni A., Montecchi-Palazzi L., Quondam M., Ausiello G., Helmer-Citterich M., Cesareni G. MINT: a Molecular INTeraction database. FEBS Lett 2002, 513:135-140.
33. Barman S., Nayak D.P. Lipid raft disruption by cholesterol depletion enhances influenza A virus budding from MDCK cells. J Virol 2007, 81:12169-12178.
34. Lee S.J., Liyanage U., Bickel P.E., Xia W., Lansbury P.T., Kosik K.S. A detergent-insoluble membrane compartment contains A beta in vivo. Nat Med 1998, 4:730-734.
35. Sells M.A., Chen M.L., Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 1987, 84:1005-1009.
36. Norton P.A., Gong Q., Mehta A.S., Lu X., Block T.M. Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells. J Virol 2003, 77:5503-5506.
37. Wang T., Zhao R., Wu Y., Kong D., Zhang L., Wu D., et al. Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells. Virol J 2011, 8:231.
38. Wang H., Ryu W.S. Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 2010, 6:e1000986.
39. Broeke AVd Characterization of the ovine ribosomal protein SA gene and its pseudogenes. BMC Genomics 2010, 11:179.
40. Fang C., Miwa T., Shen H., Song W.C. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J Immunol 2007, 179:3178-3186.
41. Liu R., Wang K., Yuan K., Wei Y., Huang C. Integrative oncoproteomics strategies for anticancer drug discovery. Expert Rev Proteomics 2010, 7:411-429.
42. Toh Q.C. Identification of cellular membrane proteins interacting with hepatitis b surface antigen using yeast split-ubiquitin system. Int J Med Sci 2005, 2:114-117.
43. Bowick G.C., Fennewald S.M., Scott E.P., Zhang L., Elsom B.L., Aronson J.F., et al. Identification of differentially activated cell-signaling networks associated with pichinde virus pathogenesis by using systems kinomics. J Virol 2007, 81:1923-1933.
44. Shih W.L., Kuo M.L., Chuang S.E., Cheng A.L., Doong S.L. Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase. J Biol Chem 2003, 278:31807-31813.
45. Chung T.-W., Lee Y.-C., Kim C.-H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J 2004, 18:1123-1125.
46. Chung T.W., Lee Y.C., Ko J.H., Kim C.H. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells. Cancer Res 2003, 63:3453-3458.
47. Bengoechea-Alonso M.T., Ericsson J. SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol 2007, 19:215-222.
48. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J 1995, 9:726-735.
49. Yip-Schneider M.T., Klein P.J., Wentz S.C., Zeni A., Menze A., Schmidt C.M. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. J Pharmacol Exp Ther 2009, 329:1063-1070.
50. Block T.M. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22:5093-5107.
51. Halestrap A.P., Price N.T. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 1999, 343(Pt 2):281-299.
52. Su J., Chen X., Kanekura T. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis. Cancer Lett 2009, 273:140-147.
53. Nawashiro H., Otani N., Shinomiya N., Fukui S., Ooigawa H., Shima K., et al. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 2006, 119:484-492.
54. Jain-Vakkalagadda B., Dey S., Pal D., Mitra A.K. Identification and functional characterization of a Na+-independent large neutral amino acid transporter, LAT1, in human and rabbit cornea. Invest Ophthalmol Vis Sci 2003, 44:2919-2927.
55. Broer A., Wagner C.A., Lang F., Broer S. The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine. Biochem J 2000, 349(Pt 3):787-795.
56. Fort J. The structure of human 4F2hc ectodomain provides a model for homodimerization and electrostatic interaction with plasma membrane. J Biol Chem 2007, 282:31444-31452.
57. Rasheed S., Yan J.S., Lau A., Chan A.S. HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS One 2008, 3:e3003.
58. Curry S., Mandelkow H., Brick P., Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 1998, 5:827-835.
59. Brereton P., Suzuki T., Sasano H., Li K., Duarte C., Obeyesekere V., et al. Pan1b (17bHSD11)-enzymatic activity and distribution in the lung. Mol Cell Endocrinol 2001, 171:111-117.
60. Jacquet S. The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis. Cell Mol Life Sci 2005, 62:2508-2515.
61. Champagne E., Martinez L.O., Collet X., Barbaras R. Ecto-F1Fo ATP synthase/F1 ATPase: metabolic and immunological functions. Curr Opin Lipidol 2006, 17:279-284.
62. Kim K.B., Lee J.W., Lee C.S., Kim B.W., Choo H.J., Jung S.Y., et al. Oxidation-reduction respiratory chains and ATP synthase complex are localized in detergent-resistant lipid rafts. Proteomics 2006, 6:2444-2453.
63. Bae T.J., Kim M.S., Kim J.W., Kim B.W., Choo H.J., Lee J.W., et al. Lipid raft proteome reveals ATP synthase complex in the cell surface. Proteomics 2004, 4:3536-3548.
64. Sprenger R.R., Fontijn R.D., van Marle J., Pannekoek H., Horrevoets A.J. Spatial segregation of transport and signalling functions between human endothelial caveolae and lipid raft proteomes. Biochem J 2006, 400:401-410.
65. Mielenz D. Lipid rafts associate with intracellular B cell receptors and exhibit a B cell stage-specific protein composition. J Immunol 2005, 174:3508-3517.